Peptidmodifieringstjänster
Peptidmodifiering förändrar peptidens fysikaliska och kemiska egenskaper genom att modifiera peptidens huvudkedja och sidokedjestruktur, och därigenom förbättra dess biotillgänglighet. Modifierade peptidläkemedel kan avsevärt minska immunogeniciteten, minska toxiska effekter, öka vattenlösligheten, förlänga verkningstiden i kroppen, ändra distributionen i kroppen etc. Vanliga peptidmodifieringar inkluderar: C-ändmodifiering, N-terminalmodifieringar, modifieringar av mellanliggande rester och cykliseringsmodifieringar.
N slutmodifiering
| •Ac | •Allyl | •Cholesteryl- | •N-Propargylglycin- |
| •Fmoc | • Akryl | •Fruktos- | •Annons |
| •CBZ | •Alloc | •Glukos- | •BPS- |
| •Boc | •Pyr | •DMAP-Ac | •Morfolin-4-karbonyl- |
| •Bz | •D-Pyr | •NTriAc | •Trans-Cinnamoyl |
| •Bz (5-NH2,2-NO2) | •LA- | •PhAc | •2-Furoyl |
| •Bz (4-F) | •Mpa- | •Py-Ac | •Metakryl- |
| •Bz (4-NO2) | •Tos | •N-Amidinoglycin | •BPA- |
C-ändmodifiering
| •-pNA | •-Ome | •-ONP | •-OSu |
| •-NH2 | •-OEt | •-AMC | •-NHMe |
| •-ol | •-OBzl | •-AFC | •-NHEt |
Fettsyrning
|
•För |
•MeOSuc |
•5-hexynsyra |
•F-Lau- |
|
•MeOCO |
•Iba |
•Heptandisyra |
•Myr- |
|
•2-Br-Ac |
•pentensyra |
•okt- |
•F-Myr- |
|
•2-Cl-Ac |
•pentinoyl |
•F-okt- |
•Pentadekonyl- |
|
•2-I-Ac |
•Hex- |
•Dec- |
•Vänn- |
|
•OH-Ac |
•5-heptensyra |
•Sebacinsyra |
•Cys (Pal) |
|
•3-Bromopropionyl |
•Trans-3-hexenoyl- |
•F-Dec- |
•Pam3C- |
|
•Men- |
•Linoletisk- |
•Undecyl- |
•Ste- |
|
•Suc |
•10,12-Pentakosadiynsyra |
•Lau- |
•Oktandisyra |
Metylering
| •Lys (Jag) | •Arg (Jag) | •Tyr (Jag) | •Tyr (Et) |
| •Lys (Me2) | •Arg (Me2) asymmetrisk | •Thr (Jag) | •D-Tyr (Et) |
| •Lys (Me3) | •Arg (Me2) symmetrisk | •Ser (Jag) |
Fosforylering
| •pSer | •D-pSer | •Di-webbplatser i följd | •4-platser i följd |
| •pTyr | •D-pTyr | •Trea-webbplatser i följd | •5-platser i följd |
| •pThr | •D-pThr |
Grenpeptid
| •Symmetriska 2 grenar | •Symmetriska 4 grenar | •Symmetriska 8 grenar | •Lys symmetriska 2 grenar |
| •Lys symmetriska 4 grenar | •Lys symmetrisk 8 grenar | •Ornsymmetriska 2 grenar | •Ornsymmetriska 4 grenar |
| •Ornsymmetrisk 8 Grenar | •Glu 2-grenar (ren) | •Glycerol 3 Branches ester | •Thr (Peptid2) |
| •Ser (Peptid2) | •Lys (Peptid2) |
Cyklisk peptid
| •Mono Disulfide bro | •Dubbel disulfidbrygga | •Trippel disulfidbrygga | •Slumpmässig trippel disulfidbrygga |
| •Amide Cyclic (sidokedja) av Lys | •Amide Cyclic (sidokedja) från Orn | •Oxidation mellan Se-Cys |
•Amide Cyclic (slut) |
| •Same Sequence Inter-Disulfidbrygga genom Cys-oxidation | •Different Sequence Inter-Disulfidbrygga genom Cys-oxidation | ||
Fluorescens-/färgämnesmärkning
|
•Biotin- |
•FITC- |
•Dansyl- |
•Lys (Dnp) |
|
•DeThioBiotin |
•-ED-FITC |
•-EDDansyl |
•D-Lys (Dnp) |
|
•-EDBiotin |
•-Lys (FITC)- |
•-Lys (Dansyl)- |
•Dab (Dnp) |
|
•Glu (Biotin-PEG2) |
•-Lys (FITC) |
•-Lys (Dansyl) |
•Dap (Dnp) |
|
•-Lys (biotin)- |
•Lys (Ahx-FITC) |
•Dansli-e-Lys |
•-EDDnp |
|
•-Lys (biotin) |
•FITC-e-Lys |
•Dansyl-Ahx- |
•-Lys (LC-Biotin)- |
|
•FITC-Ahx- |
•5-FAM- |
•-Lys (LC-Biotin) |
•5-TAMRA- |
|
•5,6-FAM |
•Biotin-e-Lys |
•5 (6)-TAMTA- |
•6'FAM |
|
•Lys (S-S-Biotin) |
•-EDYAMRA |
•-ED-5-FAM |
•Biotin-Ahx- |
|
•-Lys (TAMRA)- |
•-Lys (5-FAM)- |
•Orn (Bio) |
•-Lys (5-TAMRA) |
|
•Lys (5,6-FAM) |
•MCA- |
•5-TAMRA-e-Lys |
•-Lys (5-FAM) |
|
•-Lys (MCA)- |
•5-TAMRA-Acp |
•5-FAM-E-Lys |
•-Lys (MCA) |
|
•5-FAM-Ahx- |
•Lys (MCA)- |
BSA, KLH, OVA koppling
| •BSA-Peptid N-terminal | •KLH-Peptid N-terminal | •OVA-Peptid N-terminal | •BSA-Peptid C-terminal |
| •KLH-Peptid C-terminal | •OVA-Peptid C-terminal | •BSA-Peptid via Cys | •KLH-Peptid via Cys |
| •OVA-Peptid via Cys |
Phe & Tyr-derivat
|
•D-2-Cl-Phe |
•D-4-F-Phe |
•L-2-Mig-Phe |
•L-3-I-Tyr |
|
•L-2-Cl-Phe |
•L-4-F-Phe |
•D-4-Mig-Phe |
•D-3,5-DiI-Tyr |
|
•D-3-Cl-Phe |
•D-4-NO2-Phe |
•L-4-Mig-Phe |
•L-3,5-DiI-Tyr |
|
•L-3-Cl-Phe |
•L-4-NO2-Phe |
•D-4-NH2-Phe |
•D-3-NO2-Tyr |
|
•D-4-Cl-Phe |
•D-4-I-Phe |
•L-4-NH2-Phe |
•L-3-NO2-Tyr |
|
•L-4-Cl-Phe |
•L-4-I-Phe |
•D-3-Cl-Tyr |
•D-3,5-DiNO2-Tyr |
|
•D-3,4-DiCl-Phe |
•D-3-CN-Phe |
•L-3-Cl-Tyr |
•L-3,5-DiNO2-Tyr |
|
•L-3,4-DiCl-Phe |
•L-3-CN-Phe |
•D-3,5-DiCl-Tyr |
•L-3-F-Tyr |
|
•D-4-Br-Phe |
•D-4-CN-Phe |
•L-3,5-DiCl-Tyr |
•L-4-NO2-Phg |
|
•L-4-Br-Phe |
•L-4-CN-Phe |
•D-3,5-DiBr-Tyr |
•D-4-NO2-Phg |
|
•D-3-F-Phe |
•D-2-Mig-Phe |
•L-3,5-DiBr-Tyr |
•L-3,5-DiF-Phe |
|
•L-3-F-Phe |
•D-3-I-Tyr |
Länkare
| •Gly | •Ava | •AEA | •GABA |
| •Beta-Ala | •Ahx | •Väsen | •Mini-PEG |
| •Mini-PEG2 | •Mini-PEG3 | •PEG4 |
Harts
| •peptid på Wang Resin | •peptid på 2-CTC-harts | •peptid på Rink Amide AM Resin | •peptid på Rink Amide MBHA Resin |
D aminosyra
| •D-Ala | •D-Lys | •D-Glu | •D-Tyr |
| •D-Arg | •D-Mött | •D-Gln | •D-Tr |
| •D-Asp | •D-Pro | •D-Hans | •D-Trp |
| •D-Asn | •D-Phe | •D-Leu | •D-Val |
| •D-Cys | •D-Ser |
Homotyp aminosyror
|
•Har |
•HomoCit |
•beta-HomoMet |
•beta-HomoSer |
|
•D-Har |
•D-HomoCit |
•beta-HomoPro |
•beta-HomoThr |
|
•Hcy |
•HomoLeu |
•beta-HomoVal |
•beta-HomoTrp |
|
•HPh |
•HomoPro |
•beta-HomoAsp |
•beta-HomoTyr |
|
•D-HPh |
•D-HomoPro |
•beta-HomoAsn |
•Azidohomoalanin |
|
•Hse |
•beta-HomoIle |
•beta-HomoGlu |
•beta-HomoAla |
|
•D-Hse |
•beta-HomoLeu |
•beta-HomoGln |
•beta-HomoPhe |
Speciella aminosyror
|
•beta-Asp |
•3-Thi |
•D-Byt |
•Cys (pMeBzl) |
|
•D-beta-Asp |
•Aib |
•Ac6c |
•Cys (pMeOBzl) |
|
•gamma-Glu |
•Abu |
•Badda |
•Oic |
|
•D- gamma-Glu |
•D-Abu |
•Dap |
•Tic |
|
•Cys (Cam) |
•Hyp |
•Pra |
•D-Tic |
|
•D-Cys (Cam) |
•Phg |
•D-Pra |
•Cys (Bzl) |
|
•Cys (Acm) |
•D-Phg |
•Allo-Thr |
•Epsilon-Lys |
|
•Cys (tBu) |
•Nva |
•D-Allo-Thr |
•D-Epsilon-Lys |
|
•Cys (StBu) |
•D-Nva |
•Gly (allyl) |
•5-ASA |
|
•Mött (O) |
•Nle |
•D-Gly (allyl) |
•Bpa |
|
•D-Met (O) |
•D-Nle |
•Cys (pyren-maleimid) |
•Pip |
|
•Cys (SNO) |
•Cit |
•D-1-Nal |
•Nip |
|
•Met (O)2 |
•D-Cit |
•L-1-Nal |
•2-Aze |
|
•D-Met (O)2 |
•Orn |
•D-2-Nal |
•3-Aze |
|
•Lys (Ac) |
•D-Orn |
•L-2-Nal |
•[Psi (CH2NH)] |
|
•Ac-Lys |
•Penna |
•D-2-Pal |
•[CS-NH] |
|
•Lys (Dde) |
•D-Penna |
•L-2-Pal |
•Se-Met |
|
•Tle |
•Cpg |
•D-3-Pal |
•Se-Cys |
|
•Ser (oktansyra) |
•Cha |
•L-3-pal |
•DOPA |
|
•Ser (liponsyra) |
•D-Cha |
•D-4-Pal |
•isoGln |
|
•D-Ser (oktansyra) |
•Chg |
•L-4-Pal |
•D-isoGln |
|
•Arg (Boc2) |
•Asp-OMe |
•D-Glu (OtBu) |
•Lys (Z) |
|
•Arg (NO2) |
•Asp-OtBu |
•Gln (Trt) |
•Ser (Bzl) |
|
•Arg (Z2) |
•Asn (Trt) |
•Hans (Boc) |
•Ser (Trt) |
|
•Arg (pbf) |
•Cys (MMt) |
•Hans (Trt) |
•Ser (tBu) |
|
•D-Arg (pdf) |
•Cys (Trt) |
•Tyr (propargyl) |
•Tyr (tBu) |
|
•Asp (Oall) |
•D-Cys (Trt) |
•Lys (Boc) |
•Asp (OBn) |
|
•Glu (Oall) |
•Lys (DMT) |
•D-Tyr (tBu) |
•Asp (OBzl) |
|
•Glu (OBzl) |
•Lys (Fomc) |
•Thr (tBu) |
•Asp (OMe) |
|
•Glu (OMe) |
•Lys (Mtt) |
•Trp (Boc) |
•Asp (OtBu) |
|
•Glu (OtBu) |
•Lys (Trt) |
•Trp (Farnesyl) |
Varsel:
1. Ovanstående information är endast för referens, och dina anpassade peptidmodifieringskrav kommer att skickas till laboratoriet för utvärdering.
2. Om du har några krav på peptidmodifiering som inte finns med i tabellen kan du kontakta oss direkt för konsultation.